Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can a smartphone app tame high blood pressure in african americans?

NCT ID NCT06078540

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a mobile app called USeeBP in 31 African American adults with poorly controlled high blood pressure. Participants used the app alongside their usual remote monitoring program to track blood pressure readings at home. The goal was to see if the app could help improve blood pressure control and medication adherence.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
USeeBP mobile app
What this could lead to
If successful, this app could offer a simple, low-cost way for African American adults to better control their blood pressure at home.
What could go wrong
This is a small, early proof-of-concept study with only 31 participants, so results may not apply to everyone. The app only helps track health data, not treat the condition directly.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

31 people

The number who actually took part.

Started

Oct 2023

Finished

Jul 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * African American * Ages 18 to 65 years old * Able to demonstrate English reading literacy of at least 8th grade level \[Rapid Estimate of Adult Literacy in Medicine, Revised (REALM-R) score ≥ 6\] * Prior hypertension (HTN) diagnosis * Clinically measured SBP ≥ 160 mmHg recorded during at least 2 of last 4 encounters within past 2 years * UCM-RPM Hypertension Management Program current or eligible participant * Access to an Android or Apple iOS smartphone and its corresponding health app * Access to an active data plan or home Wi-Fi * Willing to use wireless electronic blood pressure cuff (eCuff) * Has access to EPIC myChart mobile app or is willing to establish myChart account and download app * Willing to download USeeBP study app to phone * Willing to download and use USeeBP app with staff assistance Exclusion Criteria: * Hypertension is managed by a specialist (specialist prescribes the anti-hypertensive therapies) * Baseline blood pressure greater than 180/110 * Prior enrollment in the study * Known pregnancy * Prisoners * Active opioid dependency * Homelessness * Psychiatric hospitalization in the last year * Serious existing medical conditions that may make BP control difficult or necessitate frequent hospitalization (cirrhosis or hepatic failure, stage IV or V chronic kidney disease, interstitial nephritis, pulmonary arterial hypertension, right heart failure, history of dementia or neurocognitive disability, advanced heart failure, organ transplant, immunosuppressive therapy, active cancer treatment, patients on hospice care), stroke or myocardial infarction in past 90 days, severe aortic stenosis * Hospital admission for primary diagnosis of hypertensive emergency, hypertensive urgency, or uncontrolled hypertension in the past 90 days

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Blood pressure are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University of Chicago

    Chicago, Illinois, 60637, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.